Cover Image
Market Research Report

Asia Pacific Glucose Monitoring Market Forecast 2019-2027

Published by Inkwood Research Product code 429441
Published Content info 179 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia Pacific Glucose Monitoring Market Forecast 2019-2027
Published: June 10, 2019 Content info: 179 Pages
Description

KEY FINDINGS

The Asia-Pacific Continuous Glucose Monitoring System (CGMS) market is predicted to evolve at 34.81% CAGR over the forecast period of 2019-2027, collecting a total of $XX million.

While the Asia-Pacific Self-Monitoring of Blood Glucose (SMBG) market is predicted to evolve at 6.28% CAGR over the forecasted period, collecting a total of $XX million by the end of 2027.

MARKET INSIGHTS

Over the last three decades, there has been an exponential increase in the number of diabetic patients, particularly in developing economies where more than XX% of the people are living with diabetes. The prevalence rate of diabetes is said to be increasing in developing countries owing to rapid and ongoing socioeconomic transition, and as a result, the healthcare expenditure had risen. This increase in expenditure is anticipated to create opportunities for the CGMS market in the upcoming years. China's glucose monitoring system market accounted for the highest revenue share in 2018, and the country currently has the highest diabetes prevalence rate because of the growing population.

COMPETITIVE INSIGHTS

Asia-Pacific region enjoys a presence of eminent market players like Becton Dickinson And Company, Roche Diagnostics, Morepen Laboratories Ltd., Insulet Corp., Wockhardt, Ypsomed, ARKRAY Inc., Senseonics Inc., Tandem Diabetes Care, Ascensia, GlySens Inc., B Braun Melsungen AG, Terumo, Apex Biotechnology Corp., Medtronic, Nemaura Medical Inc., I-Sens Inc., Johnson and Johnson, Abbott, Dexcom, and others.

Table of Contents
Product Code: 2947

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE STUDY MARKET
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
  • 2.2. BOTTOM-UP APPROACH
  • 2.3. TOP-DOWN APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. CGMS MARKET IS ANTICIPATED TO BE A FASTEST GROWING MARKET
    • 3.2.2. SELF-MONITORING OF BLOOD GLUCOSE HAS HUGE MARKET OPPORTUNITY
    • 3.2.3. COLLABORATION OF SIGNIFICANT COMPANIES TO DEVELOP INTEGRATED CGMS-ENABLED INSULIN PUMPS

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISE IN THE INCIDENCE OF DIABETES
    • 4.2.2. INCREASE IN HEALTHCARE EXPENDITURE
    • 4.2.3. INCREASED FOCUS ON RESEARCH AND DEVELOPMENT
    • 4.2.4. TECHNOLOGY INTEGRATION
    • 4.2.5. INCREASED AFFORDABILITY OF CGMS AND SMBG
    • 4.2.6. TECHNOLOGICAL ADVANCES IN GMS DEVICES
    • 4.2.7. AWARENESS AMONG THE GENERAL POPULATION
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HINDERANCE FROM GOVERNMENT REGULATIONS
    • 4.3.2. INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
    • 4.3.3. LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. RISING AWARENESS CAMPAIGNS ON DIABETES
    • 4.4.2. RISING EMERGING TECHNOLOGIES
  • 4.5. MARKET CHALLENGES
    • 4.5.1. INTENSE COMPETITION AMONG VENDORS
    • 4.5.2. INACCURACY IN READING OF GMS DEVICES
    • 4.5.3. INCREASINGLY STRINGENT GOVERNMENT REGULATIONS

5. CGMS MARKET BY COMPONENT TYPE

  • 5.1. SENSORS
  • 5.2. TRANSMITTERS AND RECEIVERS
  • 5.3. INSULIN PUMP

6. CGMS MARKET BY END-USERS

  • 6.1. HOME SETTINGS
  • 6.2. DIAGNOSTICS AND CLINICS
  • 6.3. HOSPITALS

7. CGMS MARKET BY DEMOGRAPHICS

  • 7.1. ADULT POPULATION (>14YEARS)
  • 7.2. CHILD POPULATION (≤14YEARS)

8. SMBG MARKET OVERVIEW

9. SMBG MARKET BY COMPONENT TYPE

  • 9.1. TEST STRIPS
  • 9.2. GLUCOSE METER
  • 9.3. LANCETS

10. SMBG MARKET BY END-USER

  • 10.1. HOME SETTINGS
  • 10.2. CLINICAL
  • 10.3. HOSPITAL

11. SMBG MARKET BY APPLICATION

  • 11.1. TYPE 1 DIABETES
  • 11.2. TYPE 2 DIABETES
  • 11.3. GESTATIONAL DIABETES

12. KEY ANALYTICS

  • 12.1. PORTER'S 5 FORCE ANALYSIS
    • 12.1.1. THREAT OF NEW ENTRANT
    • 12.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 12.1.3. BARGAINING POWER OF BUYERS
    • 12.1.4. BARGAINING POWER OF SUPPLIER
    • 12.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 12.2. KEY BUYING CRITERIA
  • 12.3. KEY TRENDS
    • 12.3.1. DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
    • 12.3.2. MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
    • 12.3.3. INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
    • 12.3.4. INCREASE IN NON-INVASIVE DEVICES
    • 12.3.5. ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
  • 12.4. REGULATION OF BLOOD SUGAR
  • 12.5. VALUE CHAIN ANALYSIS
  • 12.6. OPPORTUNITY MATRIX

13. REGIONAL ANALYSIS

  • 13.1. ASIA-PACIFIC (APAC)
    • 13.1.1. CHINA
      • 13.1.1.1. CHINA HEALTH AND HEALTHCARE
      • 13.1.1.2. CHINA PHARMACEUTICAL MARKET
      • 13.1.1.3. CHINA DIABETES MARKET
      • 13.1.1.4. MARKET TRENDS
    • 13.1.2. INDIA
      • 13.1.2.1. INDIA HEALTH AND HEALTHCARE
      • 13.1.2.2. INDIA REGULATORY CHANGES
      • 13.1.2.3. INDIA PHARMACEUTICAL MARKET
      • 13.1.2.4. INDIA DIABETES MARKET
    • 13.1.3. AUSTRALIA
      • 13.1.3.1. MARKET TRENDS
    • 13.1.4. JAPAN
      • 13.1.4.1. JAPAN HEALTH AND HEALTHCARE
      • 13.1.4.2. JAPAN PHARMACEUTICAL MARKET
      • 13.1.4.3. JAPAN DIABETES MARKET
      • 13.1.4.4. MARKET TRENDS
    • 13.1.5. SOUTH KOREA
      • 13.1.5.1. MARKET TRENDS
    • 13.1.6. INDONESIA
      • 13.1.6.1. MARKET TRENDS
    • 13.1.7. MALAYSIA
      • 13.1.7.1. MARKET TRENDS
    • 13.1.8. PHILIPPINES
      • 13.1.8.1. MARKET TRENDS
    • 13.1.9. THAILAND
      • 13.1.9.1. MARKET TRENDS
    • 13.1.10. VIETNAM
      • 13.1.10.1. MARKET TRENDS
    • 13.1.11. REST OF ASIA-PACIFIC (ROAP)

14. COMPETITIVE LANDSCAPE

  • 14.1. MARKET POSITION ANALYSIS
  • 14.2. COMPANY PROFILES
    • 14.2.1. ABBOTT
    • 14.2.2. APEX BIOTECHNOLOGY CORP.
    • 14.2.3. ARKRAY INC.
    • 14.2.4. ASCENSIA
    • 14.2.5. B BRAUN MELSUNGEN AG
    • 14.2.6. BECTON DICKINSON AND COMPANY
    • 14.2.7. DEXCOM
    • 14.2.8. GLYSENS INC.
    • 14.2.9. INSULET CORP
    • 14.2.10. I-SENS INC.
    • 14.2.11. JOHNSON AND JOHNSON
    • 14.2.12. MEDTRONIC
    • 14.2.13. MOREPEN LABORATORIES LTD.
    • 14.2.14. NEMAURA MEDICAL INC.
    • 14.2.15. ROCHE DIAGNOSTICS
    • 14.2.16. SENSEONICS INC.
    • 14.2.17. TANDEM DIABETES CARE
    • 14.2.18. TERUMO
    • 14.2.19. WOCKHARDT
    • 14.2.20. YPSOMED

LIST OF TABLES

  • TABLE 1 ASIA PACIFIC CGMS MARKET 2019-2027 ($ MILLION)
  • TABLE 2 ASIA PACIFIC SMBG MARKET 2019-2027 ($ MILLION)
  • TABLE 3 DIABETES PREVALENCE IN ASIA PACIFIC 2015-2040 (MILLIONS)
  • TABLE 4 ASIA PACIFIC CGMS MARKET BY COMPONENT TYPE 2019-2027 ($ MILLION)
  • TABLE 5 ASIA PACIFIC CGMS SENSORS MARKET 2019-2027 ($ MILLION)
  • TABLE 6 ASIA PACIFIC CGMS TRANSMITTERS AND RECEIVERS MARKET 2019-2027 ($ MILLION)
  • TABLE 7 ASIA PACIFIC CGMS INSULIN PUMP MARKET 2019-2027 ($ MILLION)
  • TABLE 8 ASIA PACIFIC CGMS MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 9 ASIA PACIFIC CGMS HOME SETTINGS MARKET 2019-2027 ($ MILLION)
  • TABLE 10 ASIA PACIFIC CGMS DIAGNOSTICS AND CLINICAL MARKET 2019-2027 ($ MILLION)
  • TABLE 11 ASIA PACIFIC CGMS HOSPITAL MARKET 2019-2027 ($ MILLION)
  • TABLE 12 ASIA PACIFIC CGMS MARKET BY DEMOGRAPHICS 2019-2027 ($ MILLION)
  • TABLE 13 ASIA PACIFIC CGMS ADULT POPULATION (>14YEARS) MARKET 2019-2027 ($ MILLION)
  • TABLE 14 ASIA PACIFIC CGMS CHILD POPULATION (≤14YEARS) MARKET 2019-2027 ($ MILLION)
  • TABLE 15 IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS
  • TABLE 16 SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICAS
  • TABLE 17 PRODUCT MATRIX FOR LANCETS
  • TABLE 18 ASIA PACIFIC SMBG MARKET BY COMPONENT TYPE 2019-2027 ($ MILLION)
  • TABLE 19 ASIA PACIFIC SMBG LANCETS MARKET 2019-2027 ($ MILLION)
  • TABLE 20 ASIA PACIFIC SMBG MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 21 ASIA PACIFIC SMBG HOME SETTING MARKET 2019-2027 ($ MILLION)
  • TABLE 22 ASIA PACIFIC SMBG CLINICAL MARKET 2019-2027 ($ MILLION)
  • TABLE 23 ASIA PACIFIC SMBG HOSPITAL MARKET 2019-2027 ($ MILLION)
  • TABLE 24 ASIA PACIFIC SMBG MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 25 ASIA PACIFIC SMBG TYPE 1 DIABETES MARKET 2019-2027 ($ MILLION)
  • TABLE 26 ASIA PACIFIC SMBG TYPE 2 DIABETES MARKET 2019-2027 ($ MILLION)
  • TABLE 27 ASIA PACIFIC SMBG GESTATIONAL DIABETES MARKET 2019-2027 ($ MILLION)
  • TABLE 28 ASIA PACIFIC SMBG MARKET 2019-2027 ($ MILLION)
  • TABLE 29 ASIA PACIFIC CGMS MARKET 2019-2027 ($ MILLION)
  • TABLE 30 AVERAGE PRICES IN CHINA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
  • TABLE 31 CHINA SMBG SALES CHANNEL 2019-2027 ($ MILLION)
  • TABLE 32 AVERAGE PRICES IN INDIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 33 INDIA SMBG SALES CHANNEL 2019-2027 ($ MILLION)
  • TABLE 34 AVERAGE PRICES IN AUSTRALIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 35 AUSTRALIA SMBG SALES CHANNEL 2019-2027 ($ MILLION)
  • TABLE 36 AVERAGE PRICES IN JAPAN FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 37 JAPAN SALES CHANNEL 2019-2027 ($ MILLION)
  • TABLE 38 AVERAGE PRICES IN SOUTH KOREA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 39 SOUTH KOREA SMBG SALES CHANNEL 2019-2027 ($ MILLION)
  • TABLE 40 AVERAGE PRICES IN INDONESIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 41 INDONESIA SMBG SALES CHANNEL 2019-2027 ($ MILLION)
  • TABLE 42 AVERAGE PRICES IN MALAYSIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 43 MALAYSIA SMBG SALES CHANNEL 2019-2027 ($ MILLION)
  • TABLE 44 AVERAGE PRICES IN PHILIPPINES FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 45 PHILIPPINES SMBG SALES CHANNEL 2019-2027 ($ MILLION)
  • TABLE 46 AVERAGE PRICES IN THAILAND FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 47 THAILAND SMBG SALES CHANNEL 2019-2027 ($ MILLION)
  • TABLE 48 AVERAGE PRICES IN VIETNAM FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 49 VIETNAM SMBG SALES CHANNEL 2019-2027 ($ MILLION)
  • TABLE 50 SMBG COMPANY MARKET POSITION ANALYSIS 2018
  • TABLE 51 CGMS COMPANY MARKET POSITION ANALYSIS 2018

LIST OF FIGURES

  • FIGURE 1 ASIA PACIFIC CGMS MARKET SHARE BY COMPONENT TYPE 2018 & 2027 (%)
  • FIGURE 2 ASIA PACIFIC CGMS MARKET BY SENSORS 2019-2027 ($ MILLION)
  • FIGURE 3 ASIA PACIFIC CGMS MARKET BY TRANSMITTERS AND RECEIVERS 2019-2027 ($ MILLION)
  • FIGURE 4 ASIA PACIFIC CGMS MARKET BY INSULIN PUMP 2019-2027 ($ MILLION)
  • FIGURE 5 ASIA PACIFIC CGMS SHARE BY END-USER 2018 & 2027 (%)
  • FIGURE 6 ASIA PACIFIC CGMS MARKET BY HOME SETTING 2019-2027 ($ MILLION)
  • FIGURE 7 ASIA PACIFIC CGMS MARKET BY DIAGNOSTICS AND CLINICAL 2019-2027 ($ MILLION)
  • FIGURE 8 ASIA PACIFIC CGMS MARKET BY HOSPITAL 2019-2027 ($ MILLION)
  • FIGURE 9 ASIA PACIFIC CGMS MARKET SHARE BY DEMOGRAPHICS 2018 & 2027 (%)
  • FIGURE 10 ASIA PACIFIC CGMS MARKET BY ADULT POPULATION (>14YEARS) 2019-2027 ($ MILLION)
  • FIGURE 11 ASIA PACIFIC CGMS MARKET BY CHILD POPULATION (≤14YEARS) 2019-2027 ($ MILLION)
  • FIGURE 12 ASIA PACIFIC SMBG MARKET SHARE BY COMPONENT TYPE 2018 & 2027 (%)
  • FIGURE 13 ASIA PACIFIC SMBG MARKET BY TEST STRIPS 2019-2027 ($ MILLION)
  • FIGURE 14 ASIA PACIFIC SMBG TEST STRIPS MARKET 2019-2027 ($ MILLION)
  • FIGURE 15 ASIA PACIFIC SMBG MARKET BY GLUCOSE METER 2019-2027 ($ MILLION)
  • FIGURE 16 ASIA PACIFIC SMBG GLUCOSE METER MARKET 2019-2027 ($ MILLION)
  • FIGURE 17 ASIA PACIFIC SMBG LANCETS MARKET 2019-2027 ($ MILLION)
  • FIGURE 18 ASIA PACIFIC SMBG MARKET SHARE BY END-USER 2018 & 2027 (%)
  • FIGURE 19 ASIA PACIFIC SMBG MARKET BY HOME SETTING 2019-2027 ($ MILLION)
  • FIGURE 20 ASIA PACIFIC SMBG MARKET BY CLINICAL 2019-2027 ($ MILLION)
  • FIGURE 21 ASIA PACIFIC SMBG MARKET BY HOSPITAL 2019-2027 ($ MILLION)
  • FIGURE 22 ASIA PACIFIC SMBG MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 23 ASIA PACIFIC SMBG MARKET BY TYPE 1 DIABETES 2019-2027 ($ MILLION)
  • FIGURE 24 ASIA PACIFIC SMBG MARKET BY TYPE 2 DIABETES 2019-2027 ($ MILLION)
  • FIGURE 25 ASIA PACIFIC SMBG MARKET BY GESTATIONAL DIABETES 2019-2027 ($ MILLION)
  • FIGURE 26 PORTER'S FIVE FORCE MODEL
  • FIGURE 27 VALUE CHAIN OF CGMS MARKET
  • FIGURE 28 ASIA-PACIFIC CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 29 CHINA CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 30 CHINA SMBG MARKET 2019-2027 ($ MILLION)
  • FIGURE 31 INDIA CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 32 INDIA SMBG MARKET 2019-2027 ($ MILLION)
  • FIGURE 33 AUSTRALIA CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 34 AUSTRALIA SMBG MARKET 2019-2027 ($ MILLION)
  • FIGURE 35 JAPAN CGMS MARKET REVENUE 2019-2027 ($ MILLION)
  • FIGURE 36 JAPAN SMBG MARKET REVENUE, 2019-2027 ($ MILLION)
  • FIGURE 37 SOUTH KOREA CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 38 SOUTH KOREA SMBG MARKET 2019-2027 ($ MILLION)
  • FIGURE 39 INDONESIA CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 40 INDONESIA SMBG MARKET 2019-2027 ($ MILLION)
  • FIGURE 41 MALAYSIA CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 42 MALAYSIA SMBG MARKET 2019-2027 ($ MILLION)
  • FIGURE 43 PHILIPPINES CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 44 PHILIPPINES SMBG MARKET 2019-2027 ($ MILLION)
  • FIGURE 45 THAILAND CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 46 THAILAND SMBG MARKET 2019-2027 ($ MILLION)
  • FIGURE 47 VIETNAM CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 48 VIETNAM SMBG MARKET 2019-2027 ($ MILLION)
  • FIGURE 49 REST OF ASIA PACIFIC CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 50 REST OF ASIA PACIFIC SMBG MARKET 2019-2027 ($ MILLION)
Back to Top